The global aseptic pharma processing market was valued to be $10,633.3 million in 2020 and is expected to reach $24,364.0 million by 2031, witnessing a CAGR of 7.90% during the forecast period 2021-2031.

1. 1
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
A
S
E
P
T
I
C
P
H
A
R
M
A
P
R
O
C
E
S
S
I
N
G
M
A
R
K
E
T
res
Focus on Product, Technology,
Regional and Country Analysis
Analysis and Forecast: 2021-2031
December 2021
Aseptic Pharma
Processing
Market –
Global and
Regional Analysis
Table of Content

2. 2
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
A
S
E
P
T
I
C
P
H
A
R
M
A
P
R
O
C
E
S
S
I
N
G
M
A
R
K
E
T
BIS Research is a leading market intelligence and technology research company. BIS Research publishes in-
depth market intelligence reports focusing on the market estimations, technology analysis, emerging high-
growth applications, deeply segmented granular country-level market data and other important market
parameters useful in the strategic decision making for senior management. BIS Research provides multi-client
reports, company profiles, databases, and custom research services.
Copyright © 2021 BIS Research Inc.
All Rights Reserved. This document contains highly confidential information and is the sole property of BIS
Research. Disclosing, copying, circulating, quoting or otherwise reproducing any or all contents of this
document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people
or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third
party.

3. 3
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
A
S
E
P
T
I
C
P
H
A
R
M
A
P
R
O
C
E
S
S
I
N
G
M
A
R
K
E
T
Table of Content
Executive Summary ........................................................................ 13
1. Product Definition..................................................................... 19
1.1 Inclusions.........................................................................................................19
1.2 Exclusions........................................................................................................19
2. Scope of the Work .................................................................... 20
2.1 Overview: Report Scope .................................................................................20
2.2 Segmentation of the Global Aseptic Pharma Processing Market ...............21
2.3 Assumptions and Limitations.........................................................................22
2.4 Key Questions Answered by this Report.......................................................23
3. Research Methodology............................................................. 24
3.1 Global Aseptic Pharma Processing Market: Research Methodology .........24
3.2 Primary Data Sources .....................................................................................25
3.3 Secondary Data Sources ................................................................................26
3.4 Market Estimation Model.................................................................................26
3.5 Criteria for Company Profiling........................................................................27
4. Markets.................................................................................... 28
4.1 Market Overview ..............................................................................................29
4.2 Global Aseptic Pharma Processing Market: Future Potential .....................30
4.2.1 Ecosystem Participants ..............................................................................30
4.3 Impact of COVID-19 on the Global Aseptic Pharma Processing Market
...........................................................................................................................31
4.3.1 Patent Analysis............................................................................................32
4.3.1.1 Introduction ......................................................................................................32
4.3.1.2 Patent Landscape ............................................................................................32
5. Global Aseptic Pharma Processing Market: Industry Analysis ... 33
5.1 Overview...........................................................................................................33
5.2 Policies and Regulatory Framework ..............................................................33
5.2.1 Overview ......................................................................................................33
5.2.2 Regulatory Framework in the U.S. .............................................................33

4. 4
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
A
S
E
P
T
I
C
P
H
A
R
M
A
P
R
O
C
E
S
S
I
N
G
M
A
R
K
E
T
5.2.3 Regulatory Framework in EU4 (Germany, France, Italy, Spain) and
the U.K..........................................................................................................34
5.2.4 Regulatory Framework in Asia-Pacific ......................................................35
5.3 Market Dynamics .............................................................................................36
5.3.1 Reduced Risk of High-Cost Product Loss ................................................36
5.3.2 High Growth in the Generics and Biopharmaceuticals Markets .............37
5.3.3 Growing Demand for Contract Manufacturing Organizations
(CMOs) for Aseptic Manufacturing of Pharmaceutical Products ............37
5.4 Market Challenges...........................................................................................38
5.4.1 High Capital Investment..............................................................................38
5.4.2 Lack of Skilled Personnel ...........................................................................38
5.5 Market Opportunities.......................................................................................39
5.5.1 Emergence of Data within the Aseptic Processing Industry ...................39
5.5.2 Growing Demand for Automated Products in Aseptic Pharma
Processing at the Pharmaceutical Companies.........................................39
5.5.3 Increasing Investment in R&D....................................................................40
5.5.4 Competitive Landscape ..............................................................................40
5.6 New Offerings ..................................................................................................41
5.7 Funding and Investments ...............................................................................42
5.8 Mergers and Acquisitions...............................................................................43
5.9 Synergistic Activities ......................................................................................43
5.10 Market Share Analysis, By Company.............................................................44
6. Technology .............................................................................. 46
6.1 Global Aseptic Pharma Processing Market (by Technology) ......................47
6.1.1 Drying...........................................................................................................47
6.1.2 Lyophilization ..............................................................................................48
6.1.3 Closed Vial Technology ..............................................................................49
6.1.4 Blow-Fill-Seal Technology..........................................................................50
6.1.5 Others...........................................................................................................51
7. Products .................................................................................. 53

5. 5
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
A
S
E
P
T
I
C
P
H
A
R
M
A
P
R
O
C
E
S
S
I
N
G
M
A
R
K
E
T
7.1 Global Aseptic Pharma Processing Market (by Product).............................54
7.1.1 Corticosteroids............................................................................................54
7.1.2 Long-Acting Beta Agonists/Long-Acting Muscarinic Antagonists.........55
7.1.3 Antibiotics....................................................................................................56
7.1.4 Others...........................................................................................................56
8. Region ..................................................................................... 58
8.1 North America..................................................................................................60
8.1.1 U.S. ...............................................................................................................61
8.1.2 Canada .........................................................................................................62
8.2 Europe ..............................................................................................................63
8.2.1 Germany.......................................................................................................65
8.2.2 U.K. ...............................................................................................................65
8.2.3 France...........................................................................................................66
8.2.4 Italy ...............................................................................................................67
8.2.5 Spain.............................................................................................................68
8.2.6 Rest-of-Europe.............................................................................................69
8.3 Asia-Pacific ......................................................................................................70
8.3.1 Market Dynamics.........................................................................................71
8.3.2 Japan............................................................................................................72
8.3.3 China ............................................................................................................73
8.3.4 India..............................................................................................................74
8.3.5 Australia.......................................................................................................75
8.3.6 South Korea .................................................................................................76
8.3.7 Rest-of-Asia-Pacific.....................................................................................77
8.4 Rest-of-the-World ............................................................................................78
9. Markets - Competitive Benchmarking & Company Profiles........ 79
9.1 Company Profile ..............................................................................................80
9.2 Abbvie Inc.........................................................................................................81
9.2.1 Company Overview .....................................................................................81
9.2.1.1 Role of Abbvie Inc. in Global Aseptic Pharma Processing Market ....................81

6. 6
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
A
S
E
P
T
I
C
P
H
A
R
M
A
P
R
O
C
E
S
S
I
N
G
M
A
R
K
E
T
9.2.1.2 Abbvie Inc.: Product Portfolio ...........................................................................82
9.2.2 Financials.....................................................................................................82
9.2.3 SWOT Analysis............................................................................................84
9.3 Lonza Group.....................................................................................................85
9.3.1 Company Overview .....................................................................................85
9.3.1.1 Role of Lonza Group in Global Aseptic Pharma Processing Market .................85
9.3.1.2 Lonza Group : Product Portfolio .......................................................................85
9.3.2 Financials.....................................................................................................86
9.3.3 SWOT Analysis............................................................................................87
9.4 Baxter International Inc...................................................................................88
9.4.1 Company Overview .....................................................................................88
9.4.1.1 Role of Baxter International Inc. in the Global Aseptic Pharma Processing
Market..............................................................................................................88
9.4.1.2 Baxter International Inc. : Product Portfolio ......................................................89
9.4.2 Financials.....................................................................................................89
9.4.3 SWOT Analysis............................................................................................92
9.5 August Bioservices .........................................................................................93
9.5.1 Company Overview .....................................................................................93
9.5.1.1 Role of August Bioservices in the Global Aseptic Pharma Processing
Market..............................................................................................................93
9.5.1.2 August Bioservices: Product Portfolio...............................................................93
9.5.2 SWOT Analysis............................................................................................94
9.6 Vetter Pharma ..................................................................................................95
9.6.1 Company Overview .....................................................................................95
9.6.1.1 Role of Vetter Pharma in Global Aseptic Pharma Processing Market...............95
9.6.1.2 Vetter Pharma : Product Portfolio.....................................................................95
9.6.2 SWOT Analysis............................................................................................96
9.7 Recipharm AB..................................................................................................97
9.7.1 Company Overview .....................................................................................97
9.7.1.1 Role of Recipharm AB in Global Aseptic Pharma Processing Market...............97

7. 7
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
A
S
E
P
T
I
C
P
H
A
R
M
A
P
R
O
C
E
S
S
I
N
G
M
A
R
K
E
T
9.7.2 SWOT Analysis............................................................................................99
9.8 Berkshire Sterile Manufacturing...................................................................100
9.8.1 Company Overview ...................................................................................100
9.8.1.1 Role of Berkshire Sterile Manufacturing in Global Aseptic Pharma
Processing Market .........................................................................................100
9.8.2 SWOT Analysis..........................................................................................101
9.9 Recro Pharma ................................................................................................102
9.9.1 Company Overview ...................................................................................102
9.9.1.1 Role of Recro Pharma in Global Aseptic Pharma Processing Market.............102
9.9.2 SWOT Analysis..........................................................................................103
9.10 Curia ...............................................................................................................104
9.10.1 Company Overview ...................................................................................104
9.10.1.1 Role of Curia in Global Aseptic Pharma Processing Market ...........................104
9.10.2 SWOT Analysis..........................................................................................105
9.11 Samsung Biologics .......................................................................................106
9.11.1 Company Overview ...................................................................................106
9.11.1.1 Role of Samsung Biologics in the Global Aseptic Pharma Processing
Market............................................................................................................106
9.11.1.2 Samsung Biologics : Overall Product Portfolio................................................106
9.11.2 Financials...................................................................................................107
9.11.3 SWOT Samsung Biologics Analysis........................................................108
9.12 Symbiosis Pharmaceutical Services............................................................109
9.12.1 Company Overview ...................................................................................109
9.12.1.1 Role of Symbiosis Pharmaceutical Services in the Global Aseptic Pharma
Market............................................................................................................109
9.12.1.2 Symbiosis Pharmaceutical Services: Overall Product Portfolio.......................109
9.12.2 SWOT Analysis..........................................................................................110
9.13 Catalent Pharma Solutions Inc.....................................................................111
9.13.1 Company Overview ...................................................................................111
9.13.1.1 Role of Catalent Pharma Solutions Inc.in the Global Aseptic Pharma
Market............................................................................................................111

8. 8
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
A
S
E
P
T
I
C
P
H
A
R
M
A
P
R
O
C
E
S
S
I
N
G
M
A
R
K
E
T
9.13.1.2 Catalent Pharma Solutions Inc.: Overall Product Portfolio.............................112
9.13.2 Financials...................................................................................................112
9.13.3 SWOT Analysis..........................................................................................115
9.14 Alcami Corporation .......................................................................................116
9.14.1 Company Overview ...................................................................................116
9.14.1.1 Role of Alcami Corporation in the Global Aseptic Pharma Market ..................116
9.14.1.2 Alcami Corporation : Overall Product Portfolio................................................116
9.14.2 SWOT Analysis..........................................................................................117
9.15 Wuxi AppTec..................................................................................................118
9.15.1 Company Overview ...................................................................................118
9.15.2 Role of Wuxi AppTec in the Global Aseptic Pharma Processing
Market.........................................................................................................118
9.15.3 Financials...................................................................................................119
9.15.4 Key Insights About Financial Health of the Company ...........................121
9.15.5 SWOT Analysis..........................................................................................122

9. 9
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
A
S
E
P
T
I
C
P
H
A
R
M
A
P
R
O
C
E
S
S
I
N
G
M
A
R
K
E
T
List of Figures
Figure 1: Global COVID-19 Vaccination Scenario (2021)
Figure 2: Global Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 3: Global Aseptic Pharma Processing Market: Impact Analysis
Figure 4: Global Aseptic Pharma Processing Market (by Product Type), $Million, 2020, 2025 and 2031
Figure 5: Global Aseptic Pharma Processing Market (by Technology), $Million, 2020, 2025, and2031
Figure 6: Global Aseptic Pharma Processing Market (by Region), 2020 and 2031
Figure 7: Share of Key Market Strategies and Developments, January 2017- December 2021
Figure 8: Global Aseptic Pharma Processing Market (by Segment)
Figure 9: Global Aseptic Pharma Processing Market Methodology
Figure 10: Figure 3.2: Primary Research Methodology
Figure 11: Bottom-Up Approach (Segment-Wise Analysis)
Figure 12: Global Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 13: Ecosystem: CDMOs
Figure 14: Impact of COVID-19 on the Global Aseptic Pharma Processing Market, $Million, 2020-2026
Figure 15: Patent Analysis (by Year), 2018-2021
Figure 16: Global Aseptic Pharma Processing Market, Business Dynamics
Figure 17: Share of Key Market Strategies and Developments, January 2017- December 2021
Figure 18: Share of New Offerings (by Company), January 2017- December 2021
Figure 19: Share of Fundings and Investments (by Company), January 2017- December 2021
Figure 20: Share of Mergers and Acquisitions (by Company), January 2017- December 2021
Figure 21: Share of Synergistic Activities (by Company), January 2017- December 2021
Figure 22: Market Share Analysis for Global Aseptic Pharma Processing Market, 2020
Figure 23: Global Aseptic Pharma Processing Market (by Technology)
Figure 24: Global Aseptic Pharma Processing Market (Drying), $Million, 2020-2031
Figure 25: Global Aseptic Pharma Processing Market (Lyophilization), $Million, 2020-2031
Figure 26: : Global Aseptic Pharma Processing Market (Closed Vial Technology), $Million, 2020-2031
Figure 27: : Global Aseptic Pharma Processing Market (Blow-Fill-Seal Technology), $Million, 2020-2031
Figure 28: Global Aseptic Pharma Processing Market (Others), $Million, 2020-2031
Figure 29: Global Aseptic Pharma Processing Market (by Product)
Figure 30: : Global Aseptic Pharma Processing Market (Corticosteroids), $Million, 2020-2031

10. 10
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
A
S
E
P
T
I
C
P
H
A
R
M
A
P
R
O
C
E
S
S
I
N
G
M
A
R
K
E
T
Figure 31: Global Aseptic Pharma Processing Market (Long-Acting Muscarinic Antagonists), $Million, 2020-
2031
Figure 32: Global Aseptic Pharma Processing Market (Antibiotics), $Million, 2020-2031
Figure 33: Global Aseptic Pharma Processing Market (Others), $Million, 2020-2031
Figure 34: Global Aseptic Pharma Processing Market (by Region), 2020-2031
Figure 35: Share of North America Aseptic Pharma Processing Market Revenue (by Country), $Million,
2020 and 2031
Figure 36: North America: Market Dynamics
Figure 37: U.S. Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 38: Canada Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 39: Share of Europe Aseptic Pharma Processing Market (by Country), $Million, 2021-2031
Figure 40: Europe: Market Dynamics
Figure 41: Germany Aseptic Pharma Processing Market Revenue, $Million, 2020-2031
Figure 42: U.K. Pharma Processing Market Revenue, $Million, 2020-2031
Figure 43: France Pharma Processing Market Revenue, $Million, 2020-2031
Figure 44: Italy Pharma Processing Market Revenue, $Million, 2020-2031
Figure 45: Spain Pharma Processing Market Revenue, $Million, 2020-2031
Figure 46: Rest-of-Europe Pharma Processing Market Revenue, $Million, 2020-2031
Figure 47: Asia-Pacific Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 48: Asia-Pacific: Market Dynamics
Figure 49: Revenue Contributions of Various Countries in Asia-Pacific, $Million, 2020 and 2031
Figure 50: Japan Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 51: China Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 52: India Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 53: Australia Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 54: South Korea Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 55: Rest-of-APAC Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 56: Rest-of-the-World Aseptic Pharma Processing Market, $Million, 2020-2031
Figure 57: Shares of Key Company Profiles
Figure 58: Abbvie, Inc.: Overall Financials, $Million, 2018-2020
Figure 59: Abbvie, Inc.: Revenue (by Region), $Million, 2018-2020
Figure 60: Abbvie, Inc.: R&D Expenditure, $Million, 2018-2020
Figure 61: Abbvie, Inc.: SWOT Analysis

11. 11
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
A
S
E
P
T
I
C
P
H
A
R
M
A
P
R
O
C
E
S
S
I
N
G
M
A
R
K
E
T
Figure 62: Lonza Group: Overall Financials, $Million, 2018-2020
Figure 63: Lonza Group: R&D Expenditure, $Million, 2018-2020
Figure 64: Lonza Group: SWOT Analysis
Figure 65: Baxter International Inc.: Overall Financials, $Million, 2018-2020
Figure 66: Baxter International Inc. Revenue (by Segment), $Million, 2018-2020
Figure 67: Baxter International Inc. Revenue (by Region), $Million, 2018-2020
Figure 68: Baxter International Inc.: R&D Expenditure, $Million, 2018-2020
Figure 69: Baxter International Inc.: SWOT Analysis
Figure 70: August Bioservices: SWOT Analysis
Figure 71: Vetter Pharma: SWOT Analysis
Figure 72: Recipharm AB: Overall Product Portfolio
Figure 73: Recipharm AB: SWOT Analysis
Figure 74: Berkshire Sterile Manufacturing: Overall Product Portfolio
Figure 75: Berkshire Sterile Manufacturing: SWOT Analysis
Figure 76: Recro Pharma : Overall Product Portfolio
Figure 77: Recro Pharma: SWOT Analysis
Figure 78: Curia: Overall Product Portfolio
Figure 79: Curia: SWOT Analysis
Figure 80: Samsung Biologics: Overall Financials, $Million, 2018-2020
Figure 81: Samsung Biologics Revenue (by Region), $Million, 2018-2020
Figure 82: Samsung Biologics: SWOT Analysis
Figure 83: Symbiosis Pharmaceutical Services: SWOT Analysis
Figure 84: Catalent Pharma Solutions Inc: Overall Financials, 2019-2021
Figure 85: Catalent Pharma Solutions Inc: Company Revenue (by Segments), 2019-2021
Figure 86: Catalent Pharma Solutions Inc.: R&D Expenditure, 2019-2021
Figure 87: Catalent Pharma Solutions Inc.: SWOT Analysis
Figure 88: Alcami Corporation: SWOT Analysis
Figure 89: Wuxi AppTec: Overall Product Portfolio
Figure 90: Wuxi AppTec: Overall Financials, 2018-2020
Figure 91: Wuxi AppTec: Revenue (by Segment), 2018-2020
Figure 92: Wuxi AppTec: Revenue (by Region), 2018-2020
Figure 93: Wuxi AppTec: R&D Expenditure, 2018-2020
Figure 94: Wuxi AppTec: SWOT Analysis

12. 12
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
A
S
E
P
T
I
C
P
H
A
R
M
A
P
R
O
C
E
S
S
I
N
G
M
A
R
K
E
T
Disclaimer
BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to
orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth.
This document and its contents are confidential and may not be further distributed, published or reproduced,
in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS
Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly
through incorporation in a database, marketing list, report or otherwise, or use or permit the use of information
to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce
information in legal proceedings.
Market reports are based on expectations, estimates and projections as of the date such information is
available. Any recommendation contained in this report may not be suitable for all investors or businesses.
The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while
considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to
market fluctuations and business, economic and competitive uncertainties and contingencies.
For more details regarding permission, please contact us:
Email: sales@bisresearch.com
Tel: +1 510 404 8135

13. 13
All rights reserved at BIS Research Inc.
G
L
O
B
A
L
A
S
E
P
T
I
C
P
H
A
R
M
A
P
R
O
C
E
S
S
I
N
G
M
A
R
K
E
T
BIS RESEARCH INC.
39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686
E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135
Global Delivery Center
Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,
Sector 126, Noida, U.P., 201303, India
Tel: +91 120 4261540 / 4261544
www.bisresearch.com